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Cold ischemia and the reduced long-term survival
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Cold ischemia and the reduced long-term survival of cadaveric
renal allografts.
Background. Prolonged cold ischemia time (CIT) is accom-
panied by delayed cadaveric renal allograft function and early
allograft loss, but the effect of CIT on long-term allograft sur-
vival is less certain and has not been studied in detail.
Methods. Using data from the United Network for Organ
Sharing, we identified 6465 patients who received a kidney-only
transplant of cadaveric origin for the first time in 1995. We ex-
amined the effect of CIT on the 6-year survival of these kidneys
using Cox proportional hazard analysis.
Results. The mean CIT of the kidney was 21 ± 7 hours
(mean ± SD) and correlated with the serum creatinine on dis-
charge (R = 0.20, P < 0.001) and the distance traveled by the
kidneys (R = 0.30, P < 0.001). CIT had a significant effect on
the 6-year allograft survival (a 10-hour increase in CIT was as-
sociated with a hazard risk ratio (RR) of 1.20 for graft failure
(P < 0.001) that persisted (RR = 1.40, P = 0.021) after adjusting
for donor age, recipient age and race, human leukocyte antigen
(HLA) mismatch, panel reactive antibodies, and first 6 months’
rejection treatments. Similarly, compared to CIT category of 0
to 10 hours, the 6-year graft survival was progressively worse
for 11 to 20 hours (RR = 1.03), 21 to 30 hours (RR = 1.12),
and, significantly so, for >30 hours (RR = 1.32; P = 0.011). The
gain in HLA match with increasing CIT was not uniform; for
instance, HLA match in >30 hours was lower than for 21 to
30 hours (2.4 ± 1.5 vs. 2.7 ± 1.6; P < 0.001).
Conclusion. (1) Cadaveric kidneys continue to undergo pro-
longed periods of cold ischemia; (2) prolonged cold storage is
associated with longer distance traveled by the kidneys, but is
not associated with any significant gain in tissue matching; and
(3) prolonged cold ischemia is a significant predictor of long-
term graft loss. Reducing prolonged cold ischemia by regional
distribution of organs and less stringent tissue matching may
reduce the persistent high rate of long-term loss of cadaveric
renal allografts.
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Sharing of cadaveric kidneys at national level improves
tissue matching, but often lengthens the cold ischemia
time (CIT). That prolonged CIT is a strong risk factor
for delayed graft function (DGF) and graft loss is con-
firmed by a number of earlier analyses [1, 2]. In particular,
Ojo et al demonstrated that DGF and acute transplant
rejections were significant determinants of short- and
long-term graft survival, and that CIT, among other co-
variates, was a significant factor for DGF and acute
rejections [1]. In another study, Shoskes and Cecka ex-
amined the effect of acute rejection on DGF’s influence
on renal allograft survival and suggested a worse out-
come for renal allografts with DGF and acute rejection
[2]. Using CIT as a covariate, they also noted lower long-
term survival for kidneys with longer CIT. Although there
has been a substantial improvement in the acute survival
of renal allografts, the chronic allograft loss, particularly
those from cadaveric donors, continues to occur at an un-
acceptably higher rate [3]. The other parameter that has
remained unchanged over the years is the CIT, which is
again relevant to cadaveric kidneys. A reasonable suppo-
sition based on these two observations is that the higher
long-term loss of cadaveric kidneys might be due to the
persistence of prolonged CIT. In the studies mentioned
above, CIT is essentially used as a covariate and the in-
formation provided on the effect of CIT on long-term
graft survival is far from adequate. In contrast, we pri-
marily focused on the effect of CIT on long-term graft
survival. Unlike earlier studies, we characterized CIT in
detail, examined the inter-relationships among CIT, tis-
sue matching, distance traveled by the donor kidneys and
the outcomes, and explored the effect of CIT both as a
continuous as well as a categorical variable on long-term
graft survival. Our analysis demonstrates that nearly half
of the 6465 cadaveric kidneys transplanted in 1995 were
cold stored for over 20 hours, and that prolonged cold
ischemia remains a significant risk factor for long-term
graft loss. Our analysis also suggests that cold ischemia
time may correlate with the distance traveled by the kid-
neys, and may not be associated with significant gain in
tissue matching.
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METHODS
Study population
From the United Network for Organ Sharing (UNOS)
registry, the patients who underwent cadaveric kidney-
only transplantation for the first time in 1995 (N = 6612)
were identified. The year 1995 was chosen because this
allowed a 6-year follow-up. Patients with any form of pre-
vious transplantation were excluded to avoid introducing
the confounding effects of previous immunosuppression
and preformed antibodies on the allograft survival. A to-
tal of 6465 patients who had data on CIT, renal allograft
status, and survival time formed the final subjects of this
analysis.
Statistical analysis
Graft failure risks and survival rates were obtained
from analyses based on Cox proportional hazard mod-
els. Effect of CIT on the graft failure risk was obtained
by introducing CIT as a continuous variable, both in uni-
variate and multivariate Cox models. In the multivariate
model, known predictors of graft survival (i.e., donor age,
recipient age and race, HLA mismatch, panel reactive
antibody status, and first 6 months’ rejection treatments)
were included [1, 2, 4]. Analysis was repeated by intro-
ducing CIT as categorical variables, grouped at 10-hour
intervals (i.e., 0 to 10 hours, 11 to 20 hours, 21 to 30 hours,
and >30 hours), thus providing a clinically relatable time
frame. The UNOS data provides information on patients
who died with a functioning renal graft. This was approxi-
mately 12% of recipients used for our analysis. Therefore,
for the survival analysis, we considered two definitions of
an event in subsequent Cox models. In the first definition,
events included both allograft failures and death, regard-
less of the status of kidney function. In the second defi-
nition, subjects who died with a functioning kidney were
considered censored observations and therefore not in-
cluded as an event. Little difference was observed in the
relationship between CIT and survival using both defini-
tions of event. Therefore, the results presented here are
from the analysis using death with functioning graft con-
sidered as censored. Analysis was also repeated allowing
left censoring of the graft time to the first 6 months (i.e.,
grafts that failed during the first 6 months of transplanta-
tion were excluded), to see whether the long-term effect
of cold ischemia could be demonstrated without includ-
ing the early graft loss.
All analyses were performed using the entire study
population (i.e., 6465 recipients and graft survival time
and status were used as recorded in the UNOS database).
The results of the survival analysis are presented as haz-
ard rate ratios with 95% confidence intervals (CI). Anal-
yses of differences in covariates across CIT groups were
carried out with analysis of variance (ANOVA) and re-
ported as mean ± SD. Association between continuous
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Fig. 1. Frequency distribution of the cold ischemia time sustained by
cadaveric kidneys before transplantation.
variables was determined by simple correlation analysis.
A probability value of P < 0.05 was considered statisti-
cally significant. The analysis was carried out using SPSS
computer program, version 10.1.3 (Chicago, IL, USA)
and the findings were independently verified by two of
the authors.
RESULTS
Recipient characteristics
The mean age of the 6465 cadaveric renal allograft re-
cipients was 44 ± 14 years; 62% were males. The race
distribution was 66% white, 28% black, and 6% others.
The reported causes of renal failure were diabetes mel-
litus in 24%, hypertension in 23%, glomerulonephritis
in 25%, polycystic kidney disease in 10%, and others in
18%; the latter included renal failure from congenital,
metabolic, obstructive, infective, and malignancy causes.
These patients waited for an average 414 ± 396 days to
obtain a kidney transplant. The HLA match and the mis-
match out of a maximum of 6 were 2.1 ± 1.4 and 3.6 ±
1.5, respectively. The most recent panel reactive antibod-
ies were positive (>10%) in 8% of recipients. The mean
CIT of the kidney was 21 ± 7 hours and its frequency
distribution is presented in Figure 1.
CIT and its effect on long-term graft survival
In the univariate analysis, increase in CIT as a contin-
uous predictor was associated with a significant increase
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Table 1. Hazard risk ratio (RR) of graft failure as a function of CIT
in the univariate and multivariate Cox proportional hazard analysis
RR 95% CI P value
Univariate analysis
CIT (10 hours) 1.120 1.06–1.18 <0.001
Multivariate analysis
CIT (10 hours)a 1.140 1.02–1.25 0.020
Age, donor 1.015 1.009–1.020 <0.001
Age, recipient 0.980 0.973–0.986 <0.001
Race, recipient 1.214 1.095–1.345 <0.001
(black vs. white)
HLA mismatch 1.131 1.064–1.202 <0.001
Panel reactive antibodies 1.645 1.195–2.264 0.002
>10% vs. ≤10%
Number of rejection treatments 1.617 1.334–1.961 <0.001
in the first 6 months
CIT is cold ischemia time. CIT is used as continuous variable and the
observation begins with transplantation.
aThe effect of CIT (10 hours) on multivariate graft survival after excluding the
“number of rejection treatments in the first 6 months” variable from the model
was an RR of 1.12 (95% CI: 1.06–1.19); P < 0.001.
in the RR for graft failure (Table 1). A 10-hour increase
in CIT was attended by a 12% increase in the RR (RR =
1.12, 95% CI, 1.06–1.18; P < 0.001) for graft failure over
the 6-year period. In the multivariate analysis, despite the
inclusion of a number of known, strong predictors of graft
survival (i.e., donor age, recipient age and race, HLA mis-
match, panel reactive antibody status, and first 6 months’
rejection treatments) CIT persisted (RR = 1.14; 95% CI,
1.02–1.25; P = 0.021) as a significant risk factor for long-
term allograft failure. As expected, the covariates had sig-
nificant effects on long-term graft failure in our analysis
(Table 1). RR for long-term graft failure was significantly
higher with higher donor age, HLA mismatch, panel re-
active antibodies, and rejection treatments. Black recipi-
ents, compared to white, had significantly higher risk for
graft failure, whereas recipients’ age had a negative rela-
tionship with graft failure. In our analysis, 5% of patients
were aged less than 18 years, 30% were 18 to 40 years,
and 65% were 40 to 84 years. A univariate analysis of
recipients’ age against graft failure also showed a nega-
tive relationship (RR = 0.981, 95% CI, 0.981–0.987; P <
0.001). When this relationship was reanalyzed without
accounting for the death-associated functioning grafts,
the RR for the effect of age on graft failure was posi-
tive but did not reach statistical significance (RR = 1.002;
95% CI, 0.99–1.005; P = 0.112). It should also be noted
that for multivariate analysis, we did not include any
acute renal injury variables because these parameters are
known to be strongly associated with CIT [1, 2]. Consis-
tently, we also found that the discharge serum creatinine
closely and directly correlated with CIT (Table II), and so,
not surprisingly, due to colinearity, inclusion of discharge
serum creatinine in the multivariate analysis had ren-
dered the association between CIT and allograft survival
insignificant.
Table 2. Characteristics of the recipients and donors based on
kidneys’ cold ischemia time subgrouped into 4 categories
Category of cold ischemia time hours
Recipients’
characteristic I II III IV
(0–10) (11–20) (21–30) (>30)
Age years 44 ± 15 45 ± 14 45 ± 14 46 ± 13
Race %
White 67 66 68 62
Black 25 28 28 32
Others 8 6 4 6
Male % 61 63 62 65
Primary kidney disease %
Diabetes mellitus 20 22 22 22
Hypertension 22 22 23 24
Glomerulonephritis 25 23 27 27
Polycystic kidney 10 11 11 9
disease
Others 23 21 17 18
Waiting time for 380 ± 382 410 ± 388 428 ± 415 413 ± 415
transplantation
days
HLA
Matcha 2.1 ± 1.4 2.5 ± 1.5 2.7 ± 1.6 2.4 ± 1.5
Mismatchb 3.6 ± 1.5 3.2 ± 1.6 3.0 ± 1.8 3.3 ± 1.6
Distance traveled by 116 ± 290 170 ± 340 429 ± 613 589 ± 725
the kidneys milesc
Serum creatinine at 2.2 ± 1.9 2.7 ± 2.3 3.2 ± 2.7 3.9 ± 3.0
post-transplant
hospital
discharge mg/dLd
Donors’ characteristics
Age years 32 ± 16 34 ± 17 34 ± 18 33 ± 18
Race %
White 67 66 68 62
Black 9 12 12 12
Others 3 2 3 6
Male % 60 59 59 62
Head trauma % 36 37 37 37
aP < 0.001 by analysis of variance (ANOVA): Post-hoc Bonferroni: P < 0.05
in all interactions except II vs. IV, P = 0.14.
bP < 0.001 by ANOVA: Post-hoc Bonferroni: P < 0.05 in all comparisons
except II vs. IV, P = 0.39.
cP < 0.001 by ANOVA: Post-hoc Bonferroni: P < 0.05 in all comparisons.
dP < 0.001 by ANOVA: Post-hoc Bonferroni: P < 0.01 in all comparisons.
The effect of CIT on graft survival was reanalyzed with
CIT grouped at 10-hour intervals. Based on the 10-hour
categorization, 9% of the kidneys were stored in the cold
for 0 to 10 hours, 40% for 11 to 20 hours, 37% for 21 to
30 hours, and 14% for over 30 hours. The characteristics
of the recipients and donors based on CIT categories are
presented in Table 2.
Age, gender, primary renal disease, race, and wait of re-
cipients for the transplantation were not different among
the CIT categories. A significant correlation existed be-
tween CIT and HLA match or mismatch (both r = 0.30,
P < 0.001). However, the extent of HLA match or mis-
match with regard to CIT category was not uniform
(Table 2).
The HLA match score in CIT category >30 hours was
lower than 21 to 30 hours (2.4 ± 1.5 vs. 2.7 ± 1.6; P <
0.001) and not different from 11 to 20 hours (2.5 ± 1.5;
P = 0.14). A finding consistent to HLA match score
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was also observed with percent of transplantation with
6-antigen match. The matches were 2.5%, 3.9%, 7.2%,
and 3.8% for 0 to 10 hours, 11 to 20 hours, 21 to 30 hours,
and >30 hours CIT categories, respectively. Converse to
match, the HLA mismatch was higher >30 hours than 21
to 30 hours (3.3 ± 1.6 vs. 3.0 ± 1.8; P < 0.001) and not
different from 11 to 20 hours (3.2 ± 1.6; P = 0.36). A
significant correlation existed between the distance trav-
eled by the kidneys and the CIT (r = 0.30, P < 0.001),
such that among the CIT categories the distance from the
site of procurement of the kidney to transplantation pro-
gressively increased. The distances were 116 ± 290 miles,
170 ± 340 miles, 429 ± 613 miles, 589 ± 725 miles for
CIT 0 to 10 hours, 11 to 20 hours, 21 to 30 hours, and
>30 hours, respectively (P < 0.001 for all comparisons).
The distance traveled by the kidney, in turn, correlated
with HLA matching (R = 0.30; P < 0.001). Serum cre-
atinine levels at the time of first hospital discharge after
transplantation also showed a significant positive correla-
tion with CIT (R = 0.20; P < 0.001), and were 2.2 ± 1.9 mg/
dL, 2.7 ± 2.4 mg/dL, 3.2 ± 2.7 mg/dL, 3.9 ± 3 mg/dL for
CIT 0 to 10 hours, 11 to 20 hours, 21 to 30 hours, and >30
hour, respectively (P < 0.001 for all comparisons). With
regard to donors (Table 2), the donor characteristics of
age, gender, race, and cause of death such as head trauma
were not different among the CIT categories. When graft
survival was reanalyzed using the CIT as categorical vari-
ables, the RR again increased with increasing CIT in the
categories (P = 0.008) (Fig. 2). Compared to the referent
group of 0 to 10 hours with an assigned RR of l, the 6-year
survival was worse, but not statistically significant, for 11
to 20 hours CIT (RR = 1.03; 95% CI, 0.85–1.24; P = 0.79),
21 to 30 hours CIT (RR = 1.12; 95% CI, 0.92–1.35; P =
0.27), and significantly worse for >30 hours CIT (RR =
1.32; 95% CI, 1.07–1.63; P = 0.011).
When the analysis was repeated with accounting for
left censoring of the graft time to first 6 months (i.e., by
excluding 750 grafts that failed during the first 6 months of
transplantation to see if the detrimental long-term effect
of cold ischemia could be demonstrated without the early
loss), the above finding was reproducible; compared to
0 to 10 hours, the 6-year survival was worse for 11 to
20 hours CIT (RR = 1.10; 95% CI, 0.86–1.38; P = 0.47),
21 to 30 hours CIT (RR = 1.19; 95% CI, 0.94–1.50; P =
0.27), and significantly worse for >30 hours CIT (RR =
1.32; 95% CI, 1.01–1.72; P = 0.042).
DISCUSSION
Our analysis demonstrates that nearly half of the 6465
cadaveric kidneys transplanted in 1995 were cold stored
for over 20 hours, and that prolonged cold ischemia re-
mains a significant risk factor for long-term allograft loss.
Furthermore, prolonged cold ischemia was found to be a
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Fig. 2. Cadaveric renal allograft survival rates against 4 categories of
cold ischemia time (CIT) based on Cox regression analysis. Overall, the
survival rate was significantly different among the CIT categories (P <
0.001). Between specific groups, it was significantly lower for the CIT
category of >30 hours versus 0 to 10 hours (P = 0.011), but not between
CIT category of 0 to 10 hours and 11 to 20 hours (P = 0.7920) or 21 to
30 hours (P = 0.265).
function of distance traveled by the kidneys and, against
expectation, was not associated with any significant gain
in tissue matching.
Cadaveric renal allografts have shorter survival than
renal allografts from live donors, irrespective of whether
the live donor is related, unrelated, or well matched [5].
Donor factors such as brain death and CIT are unique
to cadaveric donors, and their influence may account for
much of the survival difference. Prolonged cold ischemia
is strongly associated with early allograft dysfunction [1],
and consistently in our analysis post-transplant discharge
serum creatinine strongly and directly correlated with
CIT. Thus, prolonged cold ischemia is attended by both
acute, as well as chronic, renal injury. A strong colinearity
between these two dependent measures on cold ischemic
injury is suggested by the fact that introduction of acute
injury variable such as discharge serum creatinine had
rendered the relationship between CIT and graft survival
insignificant. Based on the response-to-injury hypothesis
[6–8], early injury from cold ischemia may set the stage
for indolent, yet chronically progressive, damage leading
to higher rates of chronic graft loss noted in this analysis
of kidneys subjected to extended cold storage. Whether
the chronic loss of graft is a direct effect of cold ischemia
or through irreversible acute injury is an intriguing ques-
tion that requires separate analysis using follow-up renal
function.
The average CIT reported in the UNOS registry over
the years has more or less remained unchanged around
20 hours. This was not different in our analysis, with nearly
half of the kidneys stored in the cold for over 20 hours,
and 14% over 30 hours. The lack of reduction in cold
storage time over the years may partly explain for the
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persistence of delayed graft function and the persistence
of chronic allograft loss [1, 3]. In contrast, the striking
improvement in early renal allograft survival is credited
with refinement in immunosuppression therapy through
reduced frequency of early renal allograft rejection [9].
However, our finding that CIT continues to exert nega-
tive influence on the long-term graft survival even after
adjusting for the early episodes of rejection suggests that
cold injury still remains a potentially modifiable risk fac-
tor for the long-term allograft failure. Although there are
new insights into the mechanisms of cold ischemic renal
injury, as well as of chronic allograft nephropathy [10–
12], any clinical intervention to reduce chronic allograft
loss other than reducing the cold storage time is unlikely
in the near future. In our analysis, the best long-term sur-
vival was observed for kidneys with the least duration of
cold ischemia. However, the relationship between CIT
and long-term allograft failure was not strictly linear in
that, although there was progressive increase in the fail-
ure rate with increase in cold storage time, appreciable
increase in the failure rate was seen mainly in kidneys
subjected to cold storage for over 20 hours, with statis-
tically significant increase only for kidneys kept in the
cold for over 30 hours. This suggests that a CIT less than
30 hours, preferably 20 hours, is less likely to be associated
increased long-term allograft failure.
As noted in our analysis, shipping kidneys in the cold
to further distances, presumably to increase HLA match-
ing, increased the cold ischemia time. Yet kidneys that
sustained prolonged cold ischemia did not have signifi-
cantly higher HLA matching. It could be argued rightly
that shipping further away from the site of procurement
had, however, maintained the HLA matching on average
of 2.5 antigens. However, with the use of more potent and
precise immunosuppressants, the benefit of partial HLA
matching on graft survival is less clear than before [13].
Thus, as noted in our analysis, the survival of less well-
matched kidneys with shorter storage times may be bet-
ter than that of well-matched kidneys with longer storage
times. Therefore, strategies could be implemented by the
kidney-sharing networks to avoid whenever possible pro-
longed cold storage by utilizing the kidneys closer to pro-
curement sites, and, if necessary, with lower HLA match.
With the increasing scarcity for donor kidneys, the crite-
ria for useable kidneys have become less stringent [14]. In
our analysis, although best survival was seen in kidneys
subjected to least duration of cold storage, nearly 65%
of grafts that underwent more than 30 hours of cold stor-
age were still functional at 6 years. Thus, while prolonged
cold storage should be avoided as a routine practice, any
potentially viable kidney should be considered for trans-
plantation, irrespective of cold storage time.
This study is undertaken with a database that uses na-
tionwide sampling. It is in the public domain and there-
fore the validity of our analysis can be readily verified.
On the other hand, the data is observational and reported
as they were presented to the UNOS by the participat-
ing transplant centers. Furthermore, our analysis could
be carried out in many different ways. For example, one
could begin at an early period with a longer follow-up
or one could have a larger number of patients with a
longer follow-up. A third approach could be to com-
pare data of the late 1980s with the late 1990s to see if
change in immunosuppression had any influence on cold
ischemia’s effect on graft survival. We also recognize that
one could disagree with our approach of not including
acute injury parameters in the multivariate analysis ex-
amining the effect of CIT on long-term graft survival,
or, for that matter, dividing the cold ischemia time at
10-hour intervals. Although there is no specific reason
to believe that immunosuppression will be any different
among different CIT groups, one could argue that the in-
terpretation would have been more meaningful with data
on acute and chronic immunosuppression. We have used
the first 6 months to account for acute allograft rejection,
while others might have used the first 12 months. We have
used rejection episodes based on both clinical and biopsy
judgements; some would have used only biopsy-proven
rejections, albeit small in number. Although it is beyond
the immediate scope of this study, one would have liked
data on serial renal function to determine whether cold is-
chemic acute injury leads to chronic injury. We recognize
these and other potential limitations of our study and,
therefore, we suggest that conclusions are to be drawn
in the confines of our study. Our study, however, draws
attention to a less widely discussed importance of cold
ischemic injury on allograft injury, and in doing so, sheds
light on the disturbing possibility that prolonged cold is-
chemia may not necessarily be associated with any better
tissue matching. Our study also provides some clues as to
what would be a safe duration for cold ischemia and sug-
gests considering regional distribution of retrieved kid-
neys as a way to reduce cold ischemia time.
CONCLUSION
Using a subset of UNOS data on primary cadaveric kid-
ney transplants performed in 1995, we demonstrated that
cadaveric kidneys continue to be subjected to prolonged
cold ischemia periods, and the latter remains a significant
risk for long-term graft loss. Reducing cold ischemia time
by less stringent tissue matching and regional distribution
of organs may reduce the persistent high rate of long-term
cadaveric renal allograft loss.
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